Clinical Trial Update: Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating safety and efficacy of corneal collagen cross-linking in keratoconus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Drugs mentioned

• Corneal Collagen Cross-Linking (riboflavin-mediated corneal collagen cross-linking)

Snippet

Sponsor: Glaukos Corporation | Conditions: Keratoconus | Phase 3 | Status: TERMINATED